Keith Crandell

Affiliations

  • at Quanterix Corp (QTRX), 2021-10-05
  • Director at Twist Bioscience Corp (TWST), 2021-08-13
  • Large Shareholder, Director at Da32 Life Science Tech Acquisition Corp. (DALS), 2021-08-10
  • Large Shareholder at Erasca Inc. (ERAS), 2021-07-21
  • Large Shareholder at Vir Biotechnology Inc. (VIR), 2021-07-06
  • Large Shareholder at Beam Therapeutics Inc. (BEAM), 2021-06-29
  • Large Shareholder at Lyell Immunopharma Inc. (LYEL), 2021-06-23
  • Large Shareholder at Verve Therapeutics Inc. (VERV), 2021-06-23
  • Large Shareholder, Director at 908 Devices Inc. (MASS), 2021-06-21
  • Large Shareholder at Karuna Therapeutics Inc. (KRTX), 2021-04-15
  • Large Shareholder at Sana Biotechnology Inc. (SANA), 2021-02-11
  • Large Shareholder at Codiak Biosciences Inc. (CDAK), 2020-10-21
  • Large Shareholder at Metacrine Inc. (MTCR), 2020-09-22
  • Large Shareholder at Denali Therapeutics Inc. (DNI), 2019-08-13
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2019-07-17
  • Director at Adesto Technologies Corp (IOTS), 2019-06-06
  • Large Shareholder at Homology Medicines Inc. (FIXX), 2019-05-23
  • Large Shareholder at Sienna Biopharmaceuticals Inc. (SNNA), 2019-02-27
  • Large Shareholder at Gossamer Bio Inc. (GOSS), 2019-02-12
  • Large Shareholder at Scholar Rock Holding Corp (SRRK), 2018-06-01
  • Large Shareholder at Unity Biotechnology Inc. (UBX), 2018-05-07
  • Other at Pulmatrix Inc. (PULM), 2018-04-12
  • Large Shareholder at Xtera Communications Inc. (XCOM), 2016-10-13
  • Large Shareholder at Impinj Inc (PI), 2016-08-31
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-25
  • Large Shareholder at Juno Therapeutics Inc. (JUNO), 2016-03-18
  • Large Shareholder at Juno Lighting Inc (JUNO), 2016-03-18
  • Large Shareholder at Vbi Vaccines Inc. (VBIV), 2015-08-17
  • Large Shareholder at Sage Therapeutics Inc. (SAGE), 2015-06-22
  • Large Shareholder at Bellerophon Therapeutics Inc. (BLPH), 2015-02-24
  • Large Shareholder at Agios Pharmaceuticals Inc (AGIO), 2015-02-23
  • Large Shareholder at Receptos Inc. (RCPT), 2014-05-15
  • Large Shareholder at Achaogen Inc (AKAO), 2014-03-17
  • Large Shareholder at Fate Therapeutics Inc (FATE), 2013-10-07
  • Large Shareholder at Bluebird Bio Inc. (BLUE), 2013-06-26
  • Large Shareholder at Kythera Biopharmaceuticals Inc (KYTH), 2012-10-16
  • Large Shareholder at Neurogesx Inc (NGSX), 2011-07-26
  • Large Shareholder at Trubion Pharmaceuticals Inc (TRBN), 2010-11-01
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DALS $10.00 1,600,000 Large Shareholder, Director 1,600,000 2021-07-30 Filing
MASS $20.00 300,000 Large Shareholder, Director 5,725,045 2020-12-22 Filing
TWST $14.00 60,000 Large Shareholder, Director 954,146 2018-11-02 Filing
TWST $14.00 15,000 Large Shareholder, Director 2,407,422 2018-11-02 Filing
QTRX $15.00 266,000 Large Shareholder, Director 1,537,684 2017-12-11 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TWST $107.56 2,555 Director 76,047 2021-08-12 Filing
TWST $106.98 41,033 Director 78,602 2021-08-12 Filing
TWST $106.93 1,412 Director 486 2021-08-12 Filing
TWST $103.40 21,288 288,104 2020-12-07 Filing
TWST $103.40 53,712 726,834 2020-12-07 Filing